Melinda Hoover Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 3594 N Snyder Rd, Trotwood, OH 45426 Phone: 937-854-0878 |
Sarah Ann Drought Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 4400 N Union Rd, Trotwood, OH 45426 Phone: 937-854-4511 |
Mrs. Sandra Jacomet Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 4400 N Union Rd, Trotwood, OH 45426 Phone: 937-854-4511 |
Miss Kemba Hubbard Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3594 N Snyder Rd, Trotwood, OH 45426 Phone: 937-854-3050 |
News Archive
According to the U.S. Centers for Disease Control and Prevention, diabetes affects nearly 24 million people in the United States. In observance of National Diabetes Month, the Academy of General Dentistry (AGD) encourages those with diabetes to pay extra attention to their oral health.
An intensive program of handwashing education and promotion in Pakistan decreased the incidence of diarrhea by more than 50 percent among children, according to a study in the June 2 issue of the Journal of the American Medical Association (JAMA), a theme issue on Global Health.
Biodel Inc. announced today that the U.S. Food and Drug Administration has accepted for review the company's new drug application (NDA) seeking approval to market VIAject® for the treatment of diabetes. VIAject® is Biodel's proprietary formulation of recombinant human insulin that is designed to be absorbed into the blood faster than currently marketed rapid-acting insulin analogs.
Hospitals in the nation's more remote areas are constantly under threat. Since 2010, over 100 rural U.S. hospitals have closed, resulting in the loss of emergency department care.
Sanford Project researchers have reached a critical milestone in a clinical trial testing a combination of two medications to determine if the drugs can help patients with type 1 diabetes (T1D) keep their blood glucose levels under control with less or no insulin. The full number of patients needed to complete this first trial, termed Restore Pancreatic Insulin Response in type 1 diabetes (REPAIR-T1D), has been reached.
› Verified 5 days ago